Moreover, FN1 was found to be able to avoid the apoptotic activities of ovarian cancer cells caused by therapeutic agents, implying that the regulation of FN1 may improve the therapeutic effect (Xing et al., 2008). Here, FN1 is linked to ovarian carcinoma.